'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera

Published 2 days ago Positive
'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera
Auto

Related Stocks

NOVO-B.CO Novo Nordisk A/...
Metsera stock surged Thursday on reports Pfizer has matched Novo Nordisk's $10 billion bid to buy the obesity-focused biotech.

Continue Reading

View Comments

More News

Qualcomm earned $215 target from BofA: Here’s what could derail it

59 minutes ago Positive

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

1 hour ago Positive

Why Iren Limited Rallied Again in October

1 hour ago Positive

What IREN (IREN)'s Landmark Microsoft AI Cloud Deal Means For Shareholders

1 hour ago Positive

FLR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Fluor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLR

1 hour ago Positive